Aqua Metals Files S-1 for Lincoln Park Resale, Seeks $9.1M More Funding

TL;DR

**Aqua Metals is diluting shareholders to fund its operations through a flexible equity line with Lincoln Park, signaling ongoing capital needs for its innovative but unproven recycling tech.**

AI Summary

Aqua Metals, Inc. (AQMS) filed an S-1 to register up to 1,000,000 shares of common stock for resale by Lincoln Park Capital Fund, LLC, stemming from a May 15, 2025, Purchase Agreement. Under this agreement, Lincoln Park committed to purchase up to $10,000,000 of AQMS common stock. Prior to this filing, Aqua Metals had already sold $903,392 worth of common stock to Lincoln Park, representing 177,283 shares, in addition to 22,717 shares issued as a commitment fee. The company will not receive proceeds from the resale of these 1,000,000 shares by Lincoln Park, but may receive up to an additional $9,096,608 from future sales to Lincoln Park. The S-1 highlights Aqua Metals' focus on its patented AquaRefining technologies for cleaner metal recycling, particularly for lithium-ion batteries, aiming to produce high-purity metals like lithium hydroxide, nickel, cobalt, and copper. The company's common stock is listed on the Nasdaq Capital Market under 'AQMS', with a closing price of $6.77 on October 1, 2025. A one-for-ten reverse stock split was effected on August 4, 2025.

Why It Matters

This S-1 filing is crucial for investors as it outlines a significant financing mechanism for Aqua Metals, allowing them to raise up to an additional $9.09 million from Lincoln Park Capital. While the immediate resale by Lincoln Park won't directly fund AQMS, the underlying Purchase Agreement provides a flexible capital injection for working capital and general corporate purposes, essential for a company in the development stage of its AquaRefining technology. The potential dilution from up to 1,000,000 new shares being issued to Lincoln Park, on top of the 200,000 already issued, could impact existing shareholders' equity and voting power. In the competitive sustainable recycling market, securing this funding is vital for Aqua Metals to continue developing its Li AquaRefining process and compete against traditional pyrometallurgical and hydrometallurgical methods.

Risk Assessment

Risk Level: high — The filing explicitly states, "Investing in our securities involves a high degree of risk." The company is in the process of demonstrating its Li AquaRefining technology for commercial quantities, indicating it is not yet fully commercialized or profitable. The reliance on an 'at-the-market' type offering with Lincoln Park, where the company controls the timing and amount of sales, exposes it to market price fluctuations, especially given the $0.50 per share minimum price threshold for regular purchases and the potential for significant dilution from up to 1,000,000 additional shares.

Analyst Insight

Investors should carefully evaluate Aqua Metals' long-term financial viability and the potential for significant dilution from this financing arrangement. Monitor the company's progress in commercializing its AquaRefining technology and its ability to generate revenue, as the current funding mechanism suggests ongoing capital requirements. Consider the impact of the 1-for-10 reverse stock split on August 4, 2025, and the current share price relative to the $0.50 minimum purchase price for Lincoln Park.

Key Numbers

• $10,000,000 — Maximum commitment from Lincoln Park (Aggregate amount of shares Lincoln Park committed to purchase under the Purchase Agreement)
• 1,000,000 — Shares of common stock offered for resale (Maximum number of shares Lincoln Park may sell from time to time)
• $903,392 — Gross proceeds from prior sales to Lincoln Park (Amount of common stock sold to Lincoln Park prior to this prospectus)
• $9,096,608 — Potential future gross proceeds (Maximum aggregate gross proceeds Aqua Metals may receive from future sales to Lincoln Park)
• $6.77 — Closing price of common stock (Closing price on Nasdaq Capital Market on October 1, 2025)
• 1,848,968 — Shares of Common Stock Outstanding Prior to This Offering (Total shares outstanding before the potential 1,000,000 share issuance to Lincoln Park)
• 2,848,968 — Shares of Common Stock Outstanding After This Offering (Total shares outstanding assuming the full 1,000,000 shares are issued to Lincoln Park)
• August 4, 2025 — Date of reverse stock split (Effective date of the one-for-ten reverse split of common stock)

Key Players & Entities

• Aqua Metals, Inc. (company) — Registrant and developer of AquaRefining technologies
• Lincoln Park Capital Fund, LLC (company) — Selling Stockholder and investor committed to purchasing AQMS common stock
• Stephen Cotton (person) — Chief Executive Officer of Aqua Metals, Inc.
• Daniel K. Donahue (person) — Legal counsel from Greenberg Traurig, LLP
• Securities and Exchange Commission (regulator) — Regulatory body for S-1 filing
• Nasdaq Capital Market (regulator) — Stock exchange where AQMS common stock is listed
• Greenberg Traurig, LLP (company) — Legal firm providing counsel

FAQ

Risk Factors

• Dilution from Lincoln Park Transaction [high — financial]: The issuance and sale of up to $10,000,000 of common stock to Lincoln Park Capital Fund, LLC, may cause significant dilution to existing stockholders. The resale of 1,000,000 shares by Lincoln Park, or the perception of future sales, could depress the stock price. To date, $903,392 worth of shares have been sold to Lincoln Park, with up to an additional $9,096,608 potentially available for future sale.
• Stock Price Volatility and Market Perception [medium — financial]: The purchase price for shares sold to Lincoln Park fluctuates with the market price. Sales of shares by Lincoln Park, depending on market liquidity, could cause the trading price of Aqua Metals' common stock to fall. The company's stock closed at $6.77 on October 1, 2025, following a 1-for-10 reverse stock split on August 4, 2025.
• Uncertainty of Future Capital Needs [medium — financial]: The S-1 filing indicates potential future sales of up to $9,096,608 to Lincoln Park, suggesting ongoing capital needs. The company's ability to secure future funding beyond this agreement, especially given the speculative nature of its technology, remains a key risk.
• Technology Development and Commercialization Risks [high — operational]: Aqua Metals' business relies on the successful development and commercialization of its AquaRefining technologies for recycling lithium-ion batteries. Risks include achieving desired purity levels for metals like lithium hydroxide, nickel, and cobalt, and scaling the technology to meet market demand.
• Environmental and Permitting Compliance [medium — regulatory]: As a company involved in metal recycling and chemical processes, Aqua Metals faces risks related to environmental regulations, permitting, and compliance. Failure to adhere to these standards could result in significant fines, operational disruptions, or reputational damage.

Industry Context

The battery recycling industry is experiencing rapid growth driven by the increasing demand for electric vehicles and portable electronics, alongside concerns about the environmental impact of battery disposal and the security of raw material supply chains. Key players are focused on developing efficient and cost-effective recycling processes to recover valuable metals like lithium, cobalt, and nickel. Aqua Metals aims to differentiate itself with its patented AquaRefining technology, promising higher purity metals and a cleaner environmental footprint compared to traditional methods.

Regulatory Implications

Aqua Metals operates in a sector subject to stringent environmental regulations governing chemical processing and waste management. Compliance with EPA standards and obtaining necessary permits for its recycling facilities are critical. Any failure to meet these regulatory requirements could lead to significant operational disruptions, fines, and reputational damage, impacting its ability to commercialize its technology.

What Investors Should Do

1. Monitor the pace and pricing of Lincoln Park's stock purchases.
2. Evaluate the technological progress and commercialization milestones of AquaRefining.
3. Assess the company's cash burn rate and future funding requirements.

Key Dates

• 2025-05-15: Purchase Agreement with Lincoln Park Capital Fund, LLC — Established a commitment for Lincoln Park to purchase up to $10,000,000 of AQMS common stock, providing a potential source of capital.
• 2025-08-04: One-for-Ten Reverse Stock Split — Aimed to increase the per-share market price of the common stock, potentially making it more attractive to institutional investors and meeting Nasdaq listing requirements.
• 2025-10-01: Common Stock Closing Price — The stock closed at $6.77, reflecting its current market valuation post-reverse split and prior to significant dilution from the Lincoln Park agreement.

Glossary

S-1 Filing

A registration statement filed with the U.S. Securities and Exchange Commission (SEC) by companies planning to offer securities to the public. It contains detailed information about the company's business, financial condition, and the securities being offered. (This filing details the terms of the agreement with Lincoln Park Capital Fund, LLC, and the potential resale of shares.)

AquaRefining

Aqua Metals' proprietary technology for recycling metals, particularly from lithium-ion batteries, aiming for high purity and environmental sustainability. (This is the core technology driving the company's business strategy and future revenue potential.)

Commitment Shares

Shares of common stock issued to Lincoln Park Capital Fund, LLC as an upfront fee for its commitment to purchase shares under the Purchase Agreement. (These shares were issued prior to the S-1 filing and represent a cost of securing the financing facility.)

Reverse Stock Split

A corporate action where a company reduces the number of its outstanding shares by consolidating them, typically to increase the per-share price. (Aqua Metals executed a 1-for-10 reverse split on August 4, 2025, impacting share count and per-share metrics.)

Year-Over-Year Comparison

This S-1 filing follows a period where Aqua Metals has actively engaged with Lincoln Park Capital Fund, LLC, securing a commitment for up to $10,000,000 in equity financing. Prior sales to Lincoln Park have already occurred, totaling $903,392. A significant corporate action, a 1-for-10 reverse stock split, was implemented on August 4, 2025, to adjust the share structure. The filing focuses on the terms of the Lincoln Park agreement and the potential resale of shares, rather than a comprehensive update on operational performance or financial results compared to a prior period's filing.

Key Financial Figures

• $0.001 — 0 shares of our common stock, par value $0.001 per share ("common stock"), by Lincoln
• $10,000,000 — rchase from us, at our direction, up to $10,000,000 of shares of our common stock, subject
• $903,392 — rchase Agreement, of which we have sold $903,392 of common stock to the Selling Stockhol
• $9,096,608 — ckholder. However, we may receive up to $9,096,608 in aggregate gross proceeds from sales
• $6.77 — e closing price of our common stock was $6.77. Investing in our securities involves
• $10.0 million — purchase from us up to an aggregate of $10.0 million of shares of common stock, subject to c
• $0.50 — e of our common stock equals or exceeds $0.50 per share (subject to adjustment as set
• $500,000 — ale, subject to a maximum commitment of $500,000 per purchase (each such purchase, a "Re
• $150,000 — gular Purchase equal to or greater than $150,000, the Regular Purchase share limit shall
• $50,000 — e Regular Purchase share limit shall be $50,000 of our common stock. In addition, the S
• $9.1 million — der. We may receive up to approximately $9.1 million of aggregate gross proceeds under the P
• $57.20 — ve a weighted average exercise price of $57.20 per share; 105,268 shares of common st
• $9,096,608, m — ement, in the aggregate amount of up to $9,096,608, may be sold by us to the Selling Stockhol

Filing Documents

• aqms20250925_s1.htm (S-1) — 323KB
• ex_865145.htm (EX-5.1) — 8KB
• ex_864568.htm (EX-23.1) — 2KB
• ex_865146.htm (EX-FILING FEES) — 25KB
• 0001437749-25-030371.txt ( ) — 654KB
• aqms-20250630.xsd (EX-101.SCH) — 5KB
• aqms-20250630_def.xml (EX-101.DEF) — 12KB
• aqms-20250630_lab.xml (EX-101.LAB) — 27KB
• aqms-20250630_pre.xml (EX-101.PRE) — 13KB
• aqms20250925_s1_htm.xml (XML) — 3KB
• ex_865146_htm.xml (XML) — 5KB

RISK FACTORS

RISK FACTORS 4 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 7 THE LINCOLN PARK TRANSACTION 8

USE OF PROCEEDS

USE OF PROCEEDS 14

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK 15 SELLING STOCKHOLDER 16 PLAN OF DISTRIBUTION 17 LEGAL MATTERS 19 EXPERTS 19 INCORPORATION BY REFERENCE 19 WHERE YOU CAN FIND MORE INFORMATION 20 Table of Contents ABOUT THIS PROSPECTUS This prospectus is part of a registration statement that we filed with the SEC under the Securities Act. Under this prospectus, the Selling Stockholder may, from time to time, sell shares of our common stock described in this prospectus in one or more transactions, as described herein. This prospectus provides you with a general description of the securities offered by the Selling Stockholder. Any prospectus supplement may also add, update or change information contained in this prospectus. Any statement that we make in this prospectus will be modified or superseded by any inconsistent statement made by us in a prospectus supplement. For investors outside of the United States: Neither we nor the Selling Stockholder have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside of the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of our securities and the distribution of this prospectus outside of the United States. The registration statement we filed with the SEC includes exhibits that provide more detail of the matters discussed in this prospectus. This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this pro

Use of Proceeds

Use of Proceeds We will not receive any of the proceeds from the resale of the shares of common stock by the Selling Stockholder. We may receive up to approximately $9.1 million of aggregate gross proceeds under the Purchase Agreement from any sales of common stock we make to the Selling Stockholder pursuant to the Purchase Agreement, assuming that we sell the full amount of our common stock that we have the right, but not the obligation, to sell to the Selling Stockholder under the Purchase Agreement. Any proceeds that we receive from sales of shares of our common stock to the Selling Stockholder under the Purchase Agreement will be used for working capital and general corporate purposes. See "Use of Proceeds." Market for Our Shares of Common Stock Our common stock is listed on the Nasdaq Capital Market under the symbol "AQMS."

Risk Factors

Risk Factors Any investment in our common stock offered hereby is speculative and involves a high degree of risk. You should carefully consider the information set forth under "Risk Factors", commencing on page 3 of this prospectus, as well as all other information contained and incorporated by reference in this prospectus. The number of shares of common stock to be outstanding is based on 1,477,966 shares of common stock outstanding as of August 31, 2025 and excludes: 199,824 shares of our common stock issuable upon vesting of outstanding restricted stock units as of August 31, 2025; 182,386 shares of our common stock issuable upon exercise of outstanding warrants as of August 31, 2025, which have a weighted average exercise price of $57.20 per share; 105,268 shares of common stock reserved for issuance and available for future grant under our 2019 Stock Incentive Plan as of August 31, 2025; 23,738 shares of common stock reserved for issuance under our Officer and Director Share Purchase Plan as of August 31, 2025; and 73,122 shares of common stock reserved for issuance under our 2022 Employee Stock Purchase Plan as August 31, 2025. Unless otherwise indicated, all information in this prospectus assumes no exercise of the outstanding options and warrants or any issuance of shares under outstanding restricted stock units, in each case as described above. 3 Table of Contents

RISK FACTORS

RISK FACTORS An investment in our common stock involves a high degree of risk. You should consider carefully the risks below and the risk and uncertainties described under the heading "Risk Factors" in Item 1A of Part I of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which is incorporated by reference in this prospectus, including our audited consolidated financial statements and the related notes, before you decide whether to purchase our common stock. If any of such risks actually occur, our business, financial condition, results of operations, cash flow and prospects could be materially and adversely affected. As a result, the trading price of our common stock could decline and you could lose all or part of your investment in our common stock. Risks Related to this Offering The issuance and sale of our common stock to the Selling Stockholder may cause dilution to our other stockholders and the sale of the shares of common stock acquired by the Selling Stockholder, or the perception that such sales may occur, could cause the price of our common stock to fall. On May 15, 2025, we entered into the Purchase Agreement with the Selling Stockholder, pursuant to which the Selling Stockholder has committed to purchase up to $10.0 million of our shares of common stock, upon the terms and subject to the conditions set forth in the Purchase Agreement. Upon the execution of the Purchase Agreement, we issued to the Selling Stockholder 22,717 shares of common stock as consideration for its irrevocable commitment (the "Commitment Shares") to purchase our shares of common stock at our direction under the Purchase Agreement and prior to the date of this prospectus we have sold 177,283 shares of our common stock to Lincoln Park for the gross proceeds of $903,392. The remaining shares of our common stock that may be issued under the Purchase Agreement, in the aggregate amount of up to $9,096,608, may be sold by us to the Selling Stockholder at o

View Full Filing

View this S-1 filing on SEC EDGAR